Latest Sustainable Innovation News

Life360 reported record Q2 2025 results with robust subscription growth and raised full-year guidance, alongside a strategic leadership transition appointing Lauren Antonoff as CEO.

Element 25 Limited is advancing its Butcherbird Manganese Mine expansion in Western Australia alongside a new US-based refinery, backed by strong financing and partnerships with major automakers for EV battery-grade manganese supply.

WiseTech Global has appointed Zubin Appoo as its permanent CEO, succeeding interim leader Andrew Cartledge who will retire later this year. Appoo’s deep company roots and broad tech leadership experience position him to steer WiseTech’s next chapter.

Locate Technologies has successfully raised $168,915 through its At-the-Market Facility, reinforcing its financial position as it continues to develop its delivery optimisation platforms.

FleetPartners has priced a A$400 million asset backed securitisation, featuring a green tranche dedicated to electric vehicle leases, marking a notable step in sustainable finance.

Ballymore Resources reports outstanding metallurgical test results from its Dittmer Project, confirming high recoveries of gold, silver, and copper through multiple processing methods, including promising cyanide alternatives.

SGH Ltd has reaffirmed its FY25 guidance for high single-digit EBIT growth while targeting a net debt to EBITDA ratio of 2.0x by year-end, underpinned by disciplined capital allocation and operational improvements across its diversified industrial, energy, and media businesses.

Foresta Group Holdings’ subsidiary partners with New Zealand’s EECA to explore geothermal steam for its flagship biomass facility, aiming to boost sustainability and efficiency.

Sparc Technologies has successfully raised up to A$2.7 million through a share placement and a Share Purchase Plan, positioning the company to accelerate commercialisation of its graphene additive ecosparc and support its green hydrogen pilot projects.

Talga Group advances its European battery materials ambitions with EU Strategic Project recognitions for its graphite mine and anode refinery, alongside a €70 million Innovation Fund grant.

Percheron Therapeutics has discontinued its ATL1103 program and curtailed investment in ATL1102 following underwhelming trial results, while advancing talks to in-license new rare disease therapies and extending its cash runway into FY2027.

PYC Therapeutics is set to raise up to $146 million through a pro-rata entitlement offer, aiming to accelerate its RNA-based drug candidates targeting major unmet medical needs. Major shareholder support and underwriting commitments underpin the capital raise.